U.S. Drug Tariffs Spark Global Health Concerns 🌍💊
Experts warn new U.S. tariffs on drugs could drive up prices, disrupt global medical supply chains, and weaken crisis response systems. 🌍💊
PharmaNews
Read More
China Pharma Chamber Slams U.S. Trade Tactics 💊🛡️
A Chinese healthcare trade group condemns U.S. ‘unilateral trade bullying,’ vows global collaboration to protect industry rights. 🌍💊
🌍 Cross-Border Healthcare Collaboration Vital, Says Sino BioPharm CEO
Sino BioPharm CEO Eric Tse urges global healthcare collaboration, citing tech partnerships and youth-driven innovation as keys to progress.
U.S. Congress Targets Chinese Pharma in ‘Bitter Pill’ Biosecure Act
The U.S. House passes the Biosecure Act, pushing pharma firms to cut ties with Chinese suppliers by 2032. What’s behind the move? 💊🇺🇸🇨🇳